biocompatibility and predictability, they fail to provide a regenerative framework necessary for functional improvement, limiting sustained efficacy. 2 Autologous fat transfer has been used widely for correcting soft-tissue defects and contouring irregularities but is plagued by unpredictable outcomes where graft retention can range from 25 to 80 percent relative to the initial volume. 3, 4 Extracellular matrix-based scaffolds have been developed from a variety of tissues, including porcine dermis 5 or urinary bladder, 6 and human dermis, 7 and have shown exceptional clinical promise as regenerative scaffolds. Previous analysis of porcine dermal extracellular matrix scaffolds have shown that the matrix is composed primarily of structural proteins such as collagen and elastin fibrils and glycosaminoglycans, proteins that are known to promote cellular attachment, 8 proliferation, and matrix reorganization. 9 Furthermore, endogenous growth factors such as basic fibroblast growth factor and transforming growth factor-β1 that are typically found within native tissue matrices were preserved after decellularization of porcine dermis. When seeded with adipose-derived stem cells, dermal matrices induced cell differentiation toward an endothelial phenotype, exemplifying that intrinsic structural and instructive properties of the original tissue type remain in the acellular matrix. 10 Previous work with matrices derived from adipose tissue have shown unique protein profiles compared with bladder or dermal matrices and have supported adipogenesis in animal models, but have relied on seeding matrices with adipose-derived stem cells, which was implicated as the adipogenic mechanism. [11] [12] [13] Whether a matrix alone can support adipoinduction has yet to be demonstrated in both preclinical and clinical models.
Multiple methods of decellularizing adipose tissue have been addressed in the literature; however, most reports indicate that inclusion of adipose-derived stem cells is necessary for adipose tissue development in vivo. [14] [15] [16] [17] [18] We hypothesize that the adipose tissue processing method used here, capable of endogenous angiogenic and adipoinductive factor retention, will create an acellular adipose matrix that is able to promote and sustain adipogenesis in situ without addition of exogenous cells or growth factors.
MATERIALS AND METHODS

Production of Allograft Adipose Matrix
Allograft adipose matrix was derived from cadaveric human adipose recovered and screened according to American Association of Tissue Banks and U.S. Food and Drug Administration regulations and guidelines, and processed aseptically (Musculoskeletal Transplant Foundation, Edison, N.J.). Lipid was removed by means of exposure to 1-propanol (30 minutes); removal of cellular materials was performed using aqueous sodium deoxycholate under agitation (24 hours); allograft adipose matrix was disinfected using a peracetic acid-based solution (2 hours) and was dehydrated and milled, creating a room temperature-stable allograft. Allograft adipose matrix was distributed in its dehydrated form and reconstituted with saline immediately before use.
Investigation of Matrix-Based Proteins in Native Adipose Tissue and Allograft Adipose Matrix
Antigen retrieval was performed on paraffinembedded allograft adipose matrix with 10 mM sodium citrate buffer. Primary collagen I, III, IV, and VI antibodies (Abcam, Cambridge, Mass.) were used with hematoxylin counterstain (SigmaAldrich, St. Louis, Mo.). Growth factors were extracted using 4 M guanidine hydrochloride in 0.05 M Trizma (Sigma-Aldrich) or T-PER (Thermo Fisher, Waltham, Mass.) over 48 hours at 4°C. Growth factors were quantified using Luminex multiplexing (MilliporeSigma, St. Louis, Mo.) or by enzyme-linked immunosorbent assay (R&D Systems, Minneapolis, Minn.). Volume 143, Number 2 • Adipose Allograft Promotes Adipogenesis 301e transwell culture inserts in a 3-mm layer. Human adipose-derived stem cells were seeded atop the matrix, 0.2 M cells per 7-mm diameter. Confocal microscopy was performed using a Leica TCS SPII microscope (Leica, Allendale, N.J.). Fixed human adipose-derived stem cell-seeded allograft adipose matrix was stained with Phalloidin 633 and 4′,6-diamidino-2-phenylindole (all from Thermo Fisher), to visualize attachment and stretching at day 3. Lipid content was visualized by borondipyrromethene (Thermo Fisher), at days 7, 14, and 21 after cell seeding. Scanning electron microscopy was performed using FEI XL30 FEG-SEM (FEI, Hillsboro, Ore.) at 5-kV accelerating voltage on days 0, 7, and 14. Immunohistochemistry against collagen VI, collagen IV, and laminin and the adipogenic markers adiponectin, leptin, and FABP4 was performed at days 0, 7, and 14. Imaging was performed using an Olympus IX71 microscope (Olympus, Center Valley, Pa.).
In Vitro Characterization of Allograft
Evaluation of Allograft Adipose Matrix in an Immunocompromised Mouse Model
Allograft adipose matrix was reconstituted in sterile saline and injected bilaterally using a fanning technique in the subcutaneous dorsal flank of 5-to 7-week-old female Nu/Nu mice using a 16-gauge blunt-tip cannula, 0.3 cc per side. Adherence to the regulations and standards set forth by the University of Pittsburgh and the National Institutes of Health Office of Animal Care and Use were strictly followed throughout. Histologic analysis with Masson trichrome and perilipin A immunohistochemistry was performed at each study time point, 3, 6, 12, 18, and 24 weeks, with explants (n = 5).
Clinical Evaluation of Allograft Adipose Matrix in the Dorsal Wrist
The prospective pilot clinical assessment, approved by the Institutional Review Board of Concordia Clinical Research (Cedar Knolls, N.J.), investigated allograft adipose matrix injection into the subcutaneous wrist dorsum over a 16-week period. A total of 15 patients were enrolled after informed consent and approval over two sites (TriBeCa Plastic Surgery, New York, N.Y.; and Miami Hand Center, Key Biscayne, Fla.). Inclusion criteria included nonsmoking women aged 35 to 75 years, with a body mass index less than 30 kg/m 2 , and with well-controlled blood pressure; exclusions consisted of active infection, collagen disorders, vascular diseases, and deep chemical peels or light/energy-based procedures to the dorsum of the hands within the past year. Allograft adipose matrix was reconstituted using sterile saline immediately before injection according to product instruction, aliquoted into 1-cc syringes, and injected into a 1 × 5-cm site using a 19-gauge blunt-tip cannula in a fanning/tunneling manner incorporating multiple passes after administration of lidocaine 0.5% and epinephrine 1:200,000. Each patient received 2.5 to 5.5 cc of allograft adipose matrix, creating a wheal raised 2 to 3 mm. Patients were followed for 16 weeks with intermittent observation and analysis. The dominant wrist served as a control, not receiving injection. A 2-mm wrist biopsy specimen was recovered from one patient 16 months after injection. Biopsy histology included hematoxylin and eosin and staining against perilipin A (Abcam), developed with 3,3′-diaminobenzidine chromogen. Evaluation was performed by a board-certified pathologist. Statistical analysis was performed in Minitab 17 (Minitab, Inc., State College, Pa.) using the t test, where a value of p < 0.05 was considered significant.
RESULTS
Allograft Adipose Matrix Retains Membrane Proteins and Growth Factors
Essential collagens were verified in allograft adipose matrix by immunohistochemical staining. The basement membrane constituent, collagen IV, fibril-forming collagens I and III, and the microfibrillar collagen VI were confirmed in native subcutaneous adipose before allograft adipose matrix creation, and again on completion Confocal imaging demonstrated that calcein AM-stained human adipose-derived stem cells attached and infiltrated allograft adipose matrix ( Fig. 1, above, left) , further supported by fluorescein phalloidin-labeled cytoskeletal actin ( Fig. 1, above, right) . In media without adipogenic supplements, human adipose-derived stem cells produced new matrix as early as day 7 ( Fig Volume 143, Number 2 • Adipose Allograft Promotes Adipogenesis 303e microscopic and boron-dipyrromethene imagery time course, expanding on data shown (Fig. 1) , http://links.lww.com/PRS/D242.] Lipid was visualized using fluorescent boron-dipyrromethene, which showed intracellular lipid accumulation within the first 7 days of culture on allograft adipose matrix (Fig. 1, below, right) . Immunohistochemical analysis revealed that human adiposederived stem cells secreted matrix proteins and adipogenic markers. [See Figure, Supplemental Digital Content 4, which shows that allograft adipose matrix (AAM) supports in vitro adipogenesis of human adipose-derived stem cells (ASCs) seeded onto the matrix. Immunohistochemical staining of allograft adipose matrix alone, allograft adipose matrix seeded with adiposederived stem cells for 7 days, and allograft adipose matrix seeded with adipose-derived stem cells for 14 days of culture in basal medium. Scale bar = 50 μm for all images. The intended purpose was to display the inherent adipogenic capabilities of the allograft adipose matrix material using adiposederived stem cells cultured onto the matrix without differentiation-inducing media, http://links. lww.com/PRS/D243.]
Allograft Adipose Matrix Implantation in Athymic Mice Supports Adipogenesis In Situ
Bilateral injections of allograft adipose matrix in the immunocompromised mouse dorsal flank was used as the preclinical model, consistent with previous literature. [19] [20] [21] [22] [23] Here, 0.3 cc of saline-reconstituted allograft adipose matrix was injected diffusely through a 16-gauge blunt-tip cannula bilaterally (Fig. 2, above) . Grafted material was excised at 3, 6, 12, 18, and 24 weeks and examined grossly for texture and pliability. Tissue architecture remodeling was examined with Masson trichrome staining, and adipocyte presence were confirmed by means of perilipin A immunofluorescence (Fig. 2, below) . No adverse events were observed throughout the murine study. Inflammation and histiocyte presence typical of a normal wound healing response were observed at all time points. Allograft adipose matrix maintained form and was visible at week 24 grossly and histologically. Depending on the concentration at which the allograft adipose matrix was reconstituted, the percentage of material retained at week 24 was 44 ± 16 percent (n = 26 replicates).
Masson trichrome staining showed cellular infiltration by week 3, and blood vessels were present within the graft interior. 
Clinical Outcomes and Presurgical and Postsurgical Imaging
All patients received an allograft adipose matrix injection in the dorsal wrist and were monitored for 16 weeks. Follow-up suggested continual integration of the biocompatible graft, safe for subcutaneous injection. Patients (n = 15) were injected by two investigators at separate clinical locations, New York (n = 8) and Florida (n = 7), with average volumes of 4.4 ± 0.6 cc for New York and 3.3 ± 1.4 cc for Florida. Injected volumes between investigators were not statistically different (p = 0.082). Although 15 patients were enrolled in the study, results from 14 patients are included here, as one patient was not present for all evaluations. Patients underwent photography on injection and again at all follow-up time points, 2, 10, and 16 weeks after injection. At week 0, images before and after injection were taken for comparison. Wrist images were taken at the zero-degree position from the radial and ulnar perspectives. Selected images from the time course are presented in Figure 3 In the images obtained immediately after injection, the orange markings outline the 1 × 5-cm injection site; the hand in these images also displays postinjection swelling, which was common among the patients. The intended purpose was to provide a broader dorsal wrist imagery time course, expanding on data shown (Fig. 3) , inclusive of the intermediate time points, http:// links.lww.com/PRS/D245.] Patients were asked to report major and/or minor observations or occurrences. No major occurrences, which were defined as infection, allergic reaction, and/or immune response, were observed. Minor observations included wrist pain (n = 15), injectionsite redness (n = 13), injection-site swelling (n = 9), itching (n = 5), and wrist tenderness (n = 3). All minor occurrences resolved by the 2-week follow-up except for some continued minor pain (n = 3), which resolved by week 8. In addition, some migration of the material from the injection space was noted (n = 3). A scoring system was implemented, and during follow-up, physicians qualitatively assessed volume retention on a scale of 5 to −1, where 5 denoted the benchmark injection volume, 0 denoted no volume retained, and −1 denoted suspected tissue atrophy. These values were loosely correlated to percentage-based retention values proportionally scaled from 100 percent (denoted by 5) to visible tissue atrophy being described as −20 percent (denoted by −1). (See Table, The average graft retention at 16 weeks was correlated as approximately 47 percent relative to the initial injection volume (average injection volume, 3.9 ± 1.2 cc). A correlation was observed between the injected volume and the retained volume (Fig. 4, above) . For injections of 4 cc or less, there was significantly less volume retained (approximately 25 percent) compared to patients injected with 4.5 cc or more (approximately 77 percent), shown in Figure 4 , below (p = 0.012). Clinically, it was observed that the prominence of veins and tendons of the dorsal wrist were diminished after injection, and all patients presented apparent thickening and enhancement of quality of the skin through the time course. Histologic evaluation of a biopsy specimen from 16 months after injection indicated that no inflammation or necrosis was present. This segment also contained an area of hemorrhage likely caused by the biopsy (Fig. 5, left) . In another tissue segment, a small number of perilipin A-positive adipocytes were present adjacent to skin adnexa. Perilipin A-positive staining confirmed a segment containing several clusters of adipose tissue (Fig. 5, right) . Fig. 3 . Selected representative images of the dorsal wrist are shown in the radial and ulnar views in one representative patient. In the images obtained immediately after injection, the orange markings outline the 1 × 5-cm injection site; the hand in these images also displays postinjection swelling, which was common among the patients.
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DISCUSSION
Aseptically processed allograft adipose matrix from donated human tissue has been shown to possess angiogenic and adipogenic potential for remodeling and regenerating subcutaneous soft tissue through in vitro cell-matrix studies, in vivo implantation in a preclinical murine model, and preliminary clinical evaluation. Allograft adipose matrix without medium-based stimulus demonstrates human adipose-derived stem cell differentiation into adipocytes through cell morphology, secretion of adipogenic matrix proteins, and lipid accumulation. Adipogenic properties of allograft adipose matrix are also supported by the presence of host adipocytes in subcutaneously injected allograft adipose matrix in the dorsum of athymic mice as early as week 3 after injection. These results are corroborated by qualitative volumetric retention data from 14 patients assessed by two physicians, and histologic evidence of adipocytes in a biopsy specimen from one injected wrist.
The observed adipogenic properties of allograft adipose matrix are attributable at least in part to structural proteins and endogenous adipogenic and angiogenic factors associated with the extracellular matrix, which are preserved through aseptic processing. Type IV and type VI collagen are retained in allograft adipose matrix, and may provide a structural framework for adipose tissue formation. A variety of growth factors are shown to be within allograft adipose matrix, including vascular endothelial growth factor, acidic fibroblast growth factor, 25, 26 basic fibroblast growth factor-2, 27-29 insulin-like growth factor-1, and bone morphogenetic protein-9.
30,31 Advantageously, tissue necrosis factor-α, a proinflammatory adipokine up-regulated in obesity, 32 is shown to be removed by the allograft adipose matrix process. Although transforming growth factor-β has been linked to inhibition of adipogenesis, it is essential for matrix formation in adipose tissue. 33 These growth factors have been shown to be retained in allograft adipose matrix, supporting the hypothesis that allograft adipose matrix itself is inherently adipogenic.
The adipogenic nature of allograft adipose matrix is demonstrated through in vitro cell studies. Human adipose-derived stem cells cultured on allograft adipose matrix interacted with allograft adipose matrix, leading to cell attachment, proliferation, and differentiation along with extensive matrix deposition. A major characteristic of adipogenesis is cell shape transformation, as the adipocyte-bound cell changes morphology from fibroblastic to spherical. 34 Scanning electron microscopy and confocal imaging was performed to observe the cell morphology and cell-allograft adipose matrix interactions, showing that human adipose-derived stem cell integrated with allograft adipose matrix three-dimensionally. The newly synthesized extracellular matrix observed surrounding the rounded cells suggested adhesion and integration of the cells within allograft adipose matrix. Histologic analysis demonstrated that the human adipose-derived stem cells took on adipocyte morphology, underwent lipogenesis, and expressed prominent adipogenic markers, including adiponectin, 35 FABP4, 36 and leptin, 37 signifying the differentiation process of adipose-derived stem cells into adipocytes. 38 Histologic analysis further demonstrated the ability of allograft adipose matrix to promote the deposition of basement membrane components, laminin and collagen IV, and collagen VI, known to aid in graft incorporation and long-term remodeling. 18 Human adipose-derived stem cells seeded onto allograft adipose matrix in the absence of adipogenic media stimuli underwent adipogenesis, demonstrating that allograft adipose matrix retained inherent adipogenic cues that support human adipose-derived stem cell attachment, proliferation, and differentiation.
The natural adipogenic activity of allograft adipose matrix was further supported in the in vivo murine transplantation study, where perilipinpositive adipocytes were present in the injected matrix as early as week 3 after injection and increased in numbers throughout the investigation until the final time point at week 24. It was observed that allograft adipose matrix was initially infiltrated with macrophages that decreased in frequency with a corresponding increase in adipocyte concentration, which is consistent with other published studies. 39, 40 Previous research in adipose tissue engineering has shown that macrophages are critical for the formation and maintenance of adipose tissue, perhaps because macrophages promote angiogenesis. 41 Despite the success of autologous fat grafting for volumetric replacement and contouring in aesthetic and reconstructive applications, the procedure is not without its challenges, particularly in the lipodystrophic patient population that cannot sufficiently supply adipose tissue for transplantation. In the pilot clinical assessment, patients received allograft adipose matrix injections in the range of 2.5 to 5.5 cc into a 1 × 5-cm subcutaneous space of the dorsum of the nondominant wrist. Biocompatibility, volume retention, and soft-tissue rejuvenation were evaluated over a 16-week period. Graft-related redness, pain/soreness, swelling, and/or itching were demonstrated in patients between the time of injection and the first follow-up at week 2. This was most likely caused by the initial inflammation, which can be seen in the images obtained immediately after injection (Fig. 3) , and the remodeling phase corroborated by the histologic results seen in the athymic mice (see Figure, Supplemental Digital Content 5, http://links.lww.com/PRS/D244). As shown in the wrist images and the semiquantitative assessment (Fig. 4, above) , volume retention and skin thickening can be seen through the week-16 follow-up. Although the source of volume retention cannot be definitively concluded, it is hypothesized that graft remodeling may have promoted an adipogenic cascade, leading to observed volume retention. This hypothesis is corroborated by the histologic outcomes from the athymic mice at the 12-, 18-, and 24-week time points. Histologic analysis of a biopsy specimen from the clinical wrist study also showcases disparate adipocyte clusters near large vasculature accesses, supporting the hypothesis of de novo adipogenesis prompted by the injected material as the mechanism of volume retention in the patient. It should be noted that the biopsy specimen for histologic evaluation was obtained 16 months after injection, and evaluation of this kind was limited to an individual patient. Additional clinical limitations in this investigation include the total number of patients enrolled in the study, and, because this investigation marked the first clinical use of allograft adipose matrix, a range of 2.5 to 5.5 cc was injected. This range of injection volume may have led to inconsistencies in graft retention, as suggested in the volumetric analysis in Figure 4 , below.
Insufficiencies remain in understanding how allograft adipose matrix proteins interact with infiltrating host cells. Although soluble factors and membrane proteins were confirmed, their effects at each stage of the angiogenic and adipogenic cascades were not fully appreciated here. In addition, the injection-site microenvironment may be deterministic to cells infiltrating the graft, as it is populated by neighboring host tissues; because the subcutaneous spaces in the athymic mouse flank and the human dorsal wrist are limited in adipose depots, application of allograft adipose matrix into areas of higher adipose tissue content may better favor adipogenesis. Finally, the use of the athymic mouse model in this investigation may limit preclinical to clinical translation in terms of mechanisms of action, particularly if the immunogenic response plays some key role in cellular transdifferentiation from the immunomodulatory to the adipogenic pathway.
CONCLUSIONS
A structural human allograft adipose scaffold with retained endogenous proteins has been developed for applications in adipose tissue regeneration. Results from cell-matrix interactions in vitro provide evidence that the scaffold is adipoinductive when seeded with human adipose-derived stem cells. This observation is supported by histologic analyses demonstrating adipose depots in athymic mice after 24 weeks inhabiting the implantation site originally occupied by the injected allograft adipose matrix. These preclinical data support the clinical findings of sustained volume retention over 16 weeks on injection of allograft adipose matrix into the dorsal wrist, which is further corroborated by a 16-month biopsy and histologic investigation presenting perilipin-positive adipocytes residing in the allograft adipose matrix injection space.
